Search all trials

Find therapies in clinical trials near you – page 7

Search by disease and location to discover available clinical trials matching your criteria. Updated every day from authoritative EU registries.

recruiting: 3 962
countries: 28
conditions: 2 101

3 962 trials recruiting28 European countries2 101 conditions coveredUpdated today

Quick filters

T-cell type acute leukaemia

Recruiting

Registered drugNo placebo

Study on the Safety and Effectiveness of Isatuximab and Drug Combination for Adults with Relapsed or Refractory CD38 Positive T-cell Acute Lymphoblastic Leukemia

Registered drugNo placebo

Germany

Participants:18–64 years · 65+ years
Substances:Bortezomib

Contact Research Centre

Neonatal respiratory distress syndrome

Recruiting

Registered drugNo placebo

Study comparing prophylactic versus selective surfactant (poractant alfa, phospholipid fraction) administration in preterm infants with respiratory distress syndrome aged 25-30 weeks

Registered drugNo placebo

Germany

Participants:0–17 years
Substances:Poractant Alfa

Contact Research Centre

Non-small cell lung cancer+1

Recruiting

Registered drugNo placebo

Long-Term Safety Study of Dabrafenib Mesylate and Trametinib Dimethyl Sulfoxide for Patients Benefiting from Previous Treatment in Multiple Indications

Registered drugNo placebo

Germany

Participants:0–17 years · 18–64 years · 65+ years
Substances:Dabrafenib Mesylate

Contact Research Centre

Diffuse large B-cell lymphoma

Recruiting

Registered drugNo placebo

Study on High-Dose Chemotherapy with Cytarabine and Drug Combination for Elderly Patients with Primary CNS Lymphoma

Registered drugNo placebo

Germany

Participants:65+ years
Substances:Busulfan

Contact Research Centre

Eosinophilic oesophagitis

Recruiting

Registered drug

Study on Budesonide Tablets for Treating Eosinophilic Esophagitis in Adults

Registered drug

Germany

Participants:18–64 years · 65+ years
Substances:Budesonide

Contact Research Centre

Chronic lymphocytic leukaemia

Recruiting

Registered drugNo placebo

Study on Acalabrutinib, Obinutuzumab, and Venetoclax for Untreated High-Risk Chronic Lymphocytic Leukemia Patients

Registered drugNo placebo

Germany

Participants:18–64 years · 65+ years
Substances:Acalabrutinib

Contact Research Centre

Schizophrenia

Recruiting

Registered drug

Study on Clemastine and Aerobic Exercise for Improving Cognitive Function in Schizophrenia Patients

Registered drug

Germany

Participants:18–64 years · 65+ years
Substances:Clemastine

Contact Research Centre

Acute myeloid leukaemia

Recruiting

Registered drugNo placebo

Study of Gilteritinib, Venetoclax, and Azacitidine for Patients with Newly Diagnosed Acute Myeloid Leukemia and FLT3 Mutations Not Eligible for Intensive Treatment

Registered drugNo placebo

Germany

Participants:18–64 years · 65+ years
Substances:Azacitidine

Contact Research Centre

Lymphangiosarcoma+34

Recruiting

InvestigationalNo placebo

Study of Trabectedin alone versus Trabectedin with tTF-NGR combination therapy in adults with metastatic or refractory soft tissue sarcoma who failed first-line treatment

InvestigationalNo placebo

Germany

Participants:18–64 years · 65+ years
Substances:Ttf-Ngr

Contact Research Centre

Haemorrhagic stroke

Recruiting

Registered drug

Study on Eptacog Alfa for Treating Acute Hemorrhagic Stroke in Patients with Brain Bleeding

Registered drug

Germany

Participants:18–64 years · 65+ years
Substances:Eptacog Alfa (Activated)

Contact Research Centre

Medulloblastoma

Recruiting

Registered drugNo placebo

Study on Medulloblastoma Treatment in Children Aged 3-5 Using Carboplatin and Drug Combination

Registered drugNo placebo

Germany

Participants:0–17 years · 18–64 years
Substances:Carboplatin

Contact Research Centre

Study on Bortezomib and Drug Combination for Children with High-Risk Relapsed Acute Lymphoblastic Leukemia (ALL)

Recruiting

Registered drugNo placebo

Study on Bortezomib and Drug Combination for Children with High-Risk Relapsed Acute Lymphoblastic Leukemia (ALL)

Registered drugNo placebo

Germany

Participants:0–17 years
Substances:Bortezomib

Contact Research Centre

Find therapies in clinical trials near you – page 7

295 trials match your criteria

T-cell type acute leukaemia

Study on the Safety and Effectiveness of Isatuximab and Drug Combination for Adults with Relapsed or Refractory CD38 Positive T-cell Acute Lymphoblastic Leukemia

Neonatal respiratory distress syndrome

Study comparing prophylactic versus selective surfactant (poractant alfa, phospholipid fraction) administration in preterm infants with respiratory distress syndrome aged 25-30 weeks

Non-small cell lung cancer+1

Long-Term Safety Study of Dabrafenib Mesylate and Trametinib Dimethyl Sulfoxide for Patients Benefiting from Previous Treatment in Multiple Indications

Diffuse large B-cell lymphoma

Study on High-Dose Chemotherapy with Cytarabine and Drug Combination for Elderly Patients with Primary CNS Lymphoma

Eosinophilic oesophagitis

Study on Budesonide Tablets for Treating Eosinophilic Esophagitis in Adults

Chronic lymphocytic leukaemia

Study on Acalabrutinib, Obinutuzumab, and Venetoclax for Untreated High-Risk Chronic Lymphocytic Leukemia Patients

Schizophrenia

Study on Clemastine and Aerobic Exercise for Improving Cognitive Function in Schizophrenia Patients

Acute myeloid leukaemia

Study of Gilteritinib, Venetoclax, and Azacitidine for Patients with Newly Diagnosed Acute Myeloid Leukemia and FLT3 Mutations Not Eligible for Intensive Treatment

Lymphangiosarcoma+34

Study of Trabectedin alone versus Trabectedin with tTF-NGR combination therapy in adults with metastatic or refractory soft tissue sarcoma who failed first-line treatment

Haemorrhagic stroke

Study on Eptacog Alfa for Treating Acute Hemorrhagic Stroke in Patients with Brain Bleeding

Medulloblastoma

Study on Medulloblastoma Treatment in Children Aged 3-5 Using Carboplatin and Drug Combination

Study on Bortezomib and Drug Combination for Children with High-Risk Relapsed Acute Lymphoblastic Leukemia (ALL)

Study on Bortezomib and Drug Combination for Children with High-Risk Relapsed Acute Lymphoblastic Leukemia (ALL)

Explore other searches

Vaccine trials

Paediatric trials · ages 0–17

Healthy volunteers

Helpful resources

How applying through us works

What happens after you apply

Guides for patients and volunteers

Search filters

Prefer not to search? Our Concierge searches the trials for you.